Hans-jurgen J. Hurtz
Halle, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study).
Journal: European journal of haematology
Published: April 03, 2018
Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphoma.
Journal: European journal of haematology
Published: March 22, 2018
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.
Journal: Leukemia
Published: August 15, 2017
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.
Journal: Breast cancer research and treatment
Published: April 12, 2017
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study.
Journal: Clinical genitourinary cancer
Published: June 23, 2015
NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis.
Journal: Oncology research and treatment
Published: January 13, 2015
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
Journal: American journal of hematology
Published: September 02, 2014
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
Journal: Journal of cancer research and clinical oncology
Published: September 06, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026